|

Observational Copenhagen Pancreatic Cancer Study

RECRUITINGSponsored by Inna Chen, MD
Actively Recruiting
SponsorInna Chen, MD
Started2025-02-02
Est. completion2035-12-16
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06713525

Summary

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

Histologically confirmed pancreatic cancer

Exclusion Criteria:

* None

Conditions2

CancerPancreatic Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.